SpliSense Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://splisense.com
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients with Cystic Fibrosis
- First Posted Date
- 2024-05-24
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- SpliSense Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06429176
- Locations
- 🇺🇸
Boston Children'S Hospital, Boston, Massachusetts, United States
🇺🇸Nationwide Children'S Hospital, Columbus, Ohio, United States
Safety, Tolerability, and Pharmacokinetics of SPL84 in Healthy Volunteers
- First Posted Date
- 2024-01-23
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- SpliSense Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT06217952
- Locations
- 🇮🇱
Hadassah Ein Kerem Hospital Clinical Research Center, Jerusalem, Israel
© Copyright 2025. All Rights Reserved by MedPath